1180597

Amryt Pharmaceuticals, Inc. — FEI 3009569098

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 14, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)